Home › Products › Oncology › Staurinz 25mg Capsule

Staurinz 25mg Capsule

Salt Composition: MIDOSTAURIN

₹20641.00₹26249.06

Inclusive of all taxes

Staurinz 25mg Capsule

Categories: Oncology

Conditions: Anti Cancer

Product Introduction

Staurinz 25mg capsule contains the active substance midostaurin, a tyrosine kinase inhibitor used as an anti-cancer medicine. In adults with acute myeloid leukaemia (AML) and FLT3 gene mutation, it is used in combination with other chemotherapy medications. Acute myeloid leukaemia is a cancer of myeloid cells, a type of white blood cell, characterised by abnormal overproduction of these cells. The medicine is also indicated in adults for treatment of aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated haematological neoplasm (SM-AHN), or mast cell leukaemia (MCL).

Do not take Staurinz 25mg capsule if you are allergic to midostaurin or any other ingredient in this medicine. Inform your healthcare professional if you have symptoms of infection, heart disorder, lung problems, or breathing difficulties. Report to your doctor immediately if you experience fever, sore throat, mouth ulcers, cough with or without sputum, chest pain, difficulty breathing, or swelling in body parts after taking this medicine.

This medicine is not recommended for children and adolescents below 18 years of age. Before starting therapy, inform your physician if you are pregnant, breastfeeding, or planning pregnancy. Staurinz 25mg capsule may reduce fertility in men and women; discuss this with your doctor before initiating treatment.

The most common side effects of this medicine are fever with reduced blood cell counts, nausea, vomiting, headache, musculoskeletal pain, increased blood glucose levels, and respiratory tract infection.

Uses

Acute myeloid leukemia (AML) Aggressive systemic mastocytosis (ASM) Systemic mastocytosis with associated hematological neoplasm (SM-AHN) Mast cell leukemia (MCL)

How it works

Staurinz 25mg capsule is a kinase inhibitor that potently inhibits multiple receptor tyrosine kinases. It blocks the action of the kinases in the abnormal cells that express FLT3 mutant genes and stops their division and growth.

How to Use

Your doctor will decide the dose and duration of the treatment based on your disease condition, severity, and other factors. Take the Staurinz 25mg capsule as prescribed by your doctor. Do not open, break, crush, or chew the capsules. Swallow the capsule whole with a glass of water. Take the capsules with food at the same time each day.

Side Effects

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Common Swelling in the lower limbs Skin rash Increased blood sugar levels Abdominal pain Constipation, diarrhea Nausea, vomiting Musculoskeletal pain Headache Bleeding from nose Upper respiratory infection Tiredness Fever Serious Heart failure GI bleeding Fever with decreased blood cell counts Hypersensitivity reactions Kidney problems Pneumonia Blood infection

Expert Tips

Do not breastfeed during the treatment with Staurinz 25mg capsule and for at least 4 months after the last dose. Avoid grapefruit juice during the treatment with this medicine. If you vomit after taking this medicine, do not take another capsule to make up the dose. If you are a male patient with a female partner with reproducing potential, use effective contraception during the treatment and for 4 months after the last dose. Your doctor will perform regular blood tests during the treatment to monitor the number of blood cells and electrolytes in your body. Your heart and lung function will also be checked regularly. This medicine may make you bleed, bruise, or get infections more easily. Take precautions to prevent illness and injury.

References

  1. Novartis Pharmaceuticals, Electronic Medicines Compendium (EMC), www.medicines.org.uk. [revised on 2022] [cited 2023 Apr 13]. Available from: https://www.medicines.org.uk/emc/product/9134/smpc
  2. Novartis Pharmaceuticals, Highlights Of Prescribing Information, Midostaurin, [revised on 2017] [cited 2023 Apr 13]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207997s000lbl.pdf
  3. Anton Wellstein, Giuseppe Giaccone, Michael B. Atkins, and Edward A. Sausville, Pathway-Targeted Therapies: Monoclonal Antibodies, Protein Kinase Inhibitors, and Various Small Molecules, Goodman & Gilman’s Pharmacological Basis of Therapeutics, 13th Edition, 2018, 1203-1236.

Safety Advice

Pregnancy: unsafe Staurinz 25mg capsule is unsafe to administer in pregnant women because it may cause birth defects. Inform your physician if you are pregnant, suspect pregnancy, or planning to become pregnant. Using effective contraception during the treatment and for at least 4 months after your last dose is necessary.

Lungs: Consult your doctor It is unknown whether Staurinz 25mg capsule can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.

Breastfeeding: unsafe Breastfeeding is not recommended in patients taking Staurinz 25mg capsule because the medicine passes into the breast milk in small amounts and may harm the baby.

Disclaimer

The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.

Written By: Muskan Patel, M.Pharm

Reviewed By: Dr. Vishwa Patel, MBBS